p53‐Knockout Mice Are Protected Against the Long‐Term Effects of Methamphetamine on Dopaminergic Terminals and Cell Bodies
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
p53‐knockout mice provide a useful model to test the role of p53 in the neurotoxic effects of drugs in vivo. To test the involvement of p53 in methamphetamine (METH)‐induced toxicity, wild‐type mice, as well as heterozygous and homozygous p53‐knockout male mice, were administered four injections of three different doses (2.5, 5.0, and 10.0 mg/kg) of the drug given at 2‐h intervals within the space of 1 day. METH caused a marked dose‐dependent loss of dopamine transporters in both the striatum and the nucleus accumbens of wild‐type mice killed 2 weeks after drug administration. However, this METH‐induced decrease in dopamine transporters was attenuated in both homozygous and heterozygous p53‐knockout mice, with homozygous animals showing significantly greater protection. The possibility for p53 involvement in METH‐induced toxicity was also supported by the observation that METH caused marked increases in p53‐like immunoreactivity in the striata of wild‐type mice and very little change in heterozygous p53‐knockout mice, whereas no p53‐like immunostaining was detected in the homozygous p53‐knockout mice. Further support for p53 involvement was provided by the fact that METH treatment caused significant decreases in dopamine transporter mRNA and the number of tyrosine hydroxylase‐positive cells in the substantia nigra pars compacta and the ventral tegmental area of wild‐type but not homozygous p53‐knockout mice killed 2 weeks after cessation of METH administration. These results provide concordant evidence for a role of the tumor suppressor, p53, in the long‐term deleterious effects of a drug acting on brain dopamine systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Invited Review Free radicals and the pathobiology of brain dopamine systems
Cadet, J. L., & Brannock, C. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00031-4 · Cited by 499
Self-citation
Cited by
McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602
Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases
Alexi, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00032-5 · Cited by 295
Hughes, P. E., Alexi, T., Walton, M., Williams, C. E., Dragunow, M., G. Clark, R., & Gluckman, P. D. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00057-4 · Cited by 253
Engelhard, K., Werner, C., Eberspächer, E., Bachl, M., Blobner, M., Hildt, E., Hutzler, P., & Kochs, E. (2003) · Anesthesia & Analgesia · doi:10.1097/00000539-200302000-00041 · Cited by 252
Ladenheim, B., Krasnova, I. N., Deng, X., Oyler, J. M., Polettini, A., Moran, T. H., Huestis, M. A., & Cadet, J. L. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1247 · Cited by 131
Self-citation
Metadata
- Authors
- Hirata, H., & Cadet, J. L.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1997-08
- Volume
- 69
- Issue
- 2
- Pages
- 780-790
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1977888667
- Cited by
- 116
- References
- 4
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: p53‐Knockout Mice Are Protected Against the Long‐Term Effects of Methamphetamine on Dopaminergic Terminals and Cell Bodies. https://app.cochat.ai/papers/10.1046/j.1471-4159.1997.69020780.x
- The paper
- Hirata, H., & Cadet, J. L. (1997). p53‐Knockout Mice Are Protected Against the Long‐Term Effects of Methamphetamine on Dopaminergic Terminals and Cell Bodies. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.1997.69020780.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.